1. Choi KH, Lee SJ, Suh YL, Kim YD. Nasal-type natural killer/T-cell lymphoma of the orbit. J Korean Ophthalmol Soc. 2004. 45:2145–2150.
2. Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology. 1998. 105:1430–1441.
3. Cimino L, Chan CC, Shen D, et al. Ocular involvement in nasal natural killer T-cell lymphoma. Int Ophthalmol. 2009. 29:275–279.
4. Hon C, Kwok AK, Shek TW, et al. Vision-threatening complications of nasal T/NK lymphoma. Am J Ophthalmol. 2002. 134:406–410.
5. Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol. 2007. 43:4–14.
6. Woog JJ, Kim YD, Yeatts RP, et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology. 2006. 113:140–147.
7. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol. 1995. 19:284–296.
8. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998. 16:70–77.
9. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997. 89:4501–4513.
10. Chan JK. Natural killer cell neoplasms. Anat Pathol. 1998. 3:77–145.